ReviewExploration of targeted anti-tumor therapy2024

CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia.

Kamonporn Kotemul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.